Toronto Dominion Bk (TD) Stock Price Declined While Beutel Goodman & Co LTD Has Trimmed Its Stake by $11.82 Million; Cvs Health (CVS) Share Value Declined While Schnieders Capital Management Cut Position

The Toronto-Dominion Bank (NYSE:TD) Logo

Schnieders Capital Management Llc decreased its stake in Cvs Health Corp (CVS) by 22.93% based on its latest 2017Q4 regulatory filing with the SEC. Schnieders Capital Management Llc sold 4,610 shares as the company’s stock declined 17.45% with the market. The institutional investor held 15,497 shares of the medical and nursing services company at the end of 2017Q4, valued at $1.12 million, down from 20,107 at the end of the previous reported quarter. Schnieders Capital Management Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $71.11B market cap company. The stock increased 1.83% or $1.26 during the last trading session, reaching $69.95. About 7.49 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 29, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Beutel Goodman & Co Ltd decreased its stake in Toronto Dominion Bk (TD) by 0.8% based on its latest 2017Q4 regulatory filing with the SEC. Beutel Goodman & Co Ltd sold 203,765 shares as the company’s stock declined 1.92% with the market. The institutional investor held 25.16M shares of the commercial banks company at the end of 2017Q4, valued at $1.48B, down from 25.36M at the end of the previous reported quarter. Beutel Goodman & Co Ltd who had been investing in Toronto Dominion Bk for a number of months, seems to be less bullish one the $104.25 billion market cap company. The stock increased 0.25% or $0.14 during the last trading session, reaching $56.15. About 935,799 shares traded. The Toronto-Dominion Bank (NYSE:TD) has risen 15.54% since April 29, 2017 and is uptrending. It has outperformed by 3.99% the S&P500.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It turned negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Cadence Cap Mngmt Ltd Liability Corp reported 0.43% of its portfolio in CVS Health Corporation (NYSE:CVS). Confluence Wealth Ltd Liability Corp owns 0.25% invested in CVS Health Corporation (NYSE:CVS) for 7,129 shares. Intersect Cap Ltd Liability Company invested in 8,299 shares or 0.32% of the stock. Farmers State Bank holds 0.33% of its portfolio in CVS Health Corporation (NYSE:CVS) for 2,805 shares. 32,350 were reported by Pring Turner Group Inc. Magellan Asset Limited owns 746 shares. Wagner Bowman reported 19,777 shares. Mutual Of America Capital Limited Liability Corporation reported 0.14% of its portfolio in CVS Health Corporation (NYSE:CVS). Quinn Opportunity Ptnrs Limited Liability Com reported 0.15% of its portfolio in CVS Health Corporation (NYSE:CVS). Ipswich Investment Mngmt has invested 0.1% in CVS Health Corporation (NYSE:CVS). Qs Invsts Limited Liability Co stated it has 294,085 shares or 0.2% of all its holdings. Exane Derivatives owns 11,645 shares. Asset owns 214,378 shares for 0.26% of their portfolio. 8,303 were accumulated by Loudon Investment Mngmt Ltd Liability Corp. Excalibur has invested 0.85% in CVS Health Corporation (NYSE:CVS).

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 12.49 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Since February 16, 2018, it had 0 insider buys, and 1 insider sale for $1.42 million activity.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 76 analyst reports since July 22, 2015 according to SRatingsIntel. On Monday, August 14 the stock rating was downgraded by Wolfe Research to “Peer Perform”. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Friday, June 9. The firm earned “Outperform” rating on Thursday, December 17 by Oppenheimer. Goldman Sachs downgraded CVS Health Corporation (NYSE:CVS) on Thursday, December 17 to “Neutral” rating. The rating was maintained by Robert W. Baird with “Hold” on Monday, September 25. Needham maintained the shares of CVS in report on Tuesday, January 2 with “Buy” rating. The firm has “Buy” rating given on Tuesday, April 17 by SunTrust. Tigress Financial initiated CVS Health Corporation (NYSE:CVS) on Friday, April 28 with “Buy” rating. Wolfe Research downgraded CVS Health Corporation (NYSE:CVS) on Wednesday, August 16 to “Hold” rating. The rating was upgraded by Needham to “Buy” on Friday, November 10.

Beutel Goodman & Co Ltd, which manages about $36.47 billion and $13.89B US Long portfolio, upped its stake in Molson Coors Canada by 239,056 shares to 3.60 million shares, valued at $301.30 million in 2017Q4, according to the filing. It also increased its holding in Ingersoll (NYSE:IR) by 88,528 shares in the quarter, for a total of 2.14M shares, and has risen its stake in Kellogg Co (NYSE:K).

Analysts await The Toronto-Dominion Bank (NYSE:TD) to report earnings on May, 24. They expect $1.16 EPS, up 16.00% or $0.16 from last year’s $1 per share. TD’s profit will be $2.15B for 12.10 P/E if the $1.16 EPS becomes a reality. After $1.23 actual EPS reported by The Toronto-Dominion Bank for the previous quarter, Wall Street now forecasts -5.69% negative EPS growth.

Among 10 analysts covering TD Bank (NYSE:TD), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. TD Bank had 23 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of The Toronto-Dominion Bank (NYSE:TD) earned “Neutral” rating by Credit Suisse on Monday, September 21. The stock of The Toronto-Dominion Bank (NYSE:TD) earned “Sector Performer” rating by IBC on Friday, August 26. The stock of The Toronto-Dominion Bank (NYSE:TD) has “Equal-Weight” rating given on Tuesday, May 23 by Barclays Capital. Bank of America initiated the shares of TD in report on Tuesday, November 1 with “Buy” rating. BMO Capital Markets maintained The Toronto-Dominion Bank (NYSE:TD) rating on Monday, August 31. BMO Capital Markets has “Outperform” rating and $57 target. On Tuesday, May 3 the stock rating was upgraded by Credit Suisse to “Outperform”. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, August 28. As per Wednesday, September 14, the company rating was maintained by Citigroup. The stock of The Toronto-Dominion Bank (NYSE:TD) has “Sector Perform” rating given on Friday, August 28 by Scotia Capital. The firm earned “Sector Perform” rating on Monday, March 13 by RBC Capital Markets.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart